开发干细胞数据系统和相关数据标准,用于细胞治疗.
Yong Zhang1,2,3,4,5, Andreas Kurtz5,6, Hongling Zhao1,4
1Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China.
Advances in experimental medicine and biology
|October 24, 2025
概括
强大的数据管理对于基于细胞的疗法至关重要. 标准化框架和人工智能等新兴技术可以提高干细胞应用的安全性,有效性和监管合规性.
科学领域:
- 生物技术和生物医学工程 生物技术和生物医学工程
- 数据科学与管理数据科学与管理
背景情况:
- 基于细胞的疗法需要先进的数据管理,以确保安全性,疗效和监管遵守.
- 当前的数据系统在整合干细胞应用的临床,制造和质量控制信息方面面临着复杂性.
研究的目的:
- 审查ISO 8472系列的干细胞数据互操作性.
- 探索新兴技术在彻底改变细胞治疗数据管理中的作用.
- 解决挑战,并概述在细胞疗法制造中实施数据标准的策略.
主要方法:
- 对ISO 8472系列标准的审查.
- 探索人工智能 (AI) 和区块链技术.
- 分析细胞疗法数据标准化和透明度方面的挑战.
主要成果:
- 标准ISO 8472系列为干细胞数据的互操作性提供了一个框架.
- 人工智能和区块链为增强数据安全,自动化和管理提供了潜力.
- 利益相关者之间的合作对于克服实施挑战至关重要.
结论:
- 全面的数据标准和互操作系统对于细胞疗法的商业化至关重要.
- 标准化数据管理建立了信任,并促进了该领域的创新.
- 需要积极的战略来确保细胞疗法制造的透明度和可扩展性.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Stem Cell Culture
6.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.0K
Cell Lines
10.0K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
10.0K
Embryonic Stem Cells
4.7K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.7K
Embryonic Stem Cells
32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K


